Suppr超能文献

相似文献

1
Nostocyclopeptides as New Inhibitors of 20S Proteasome.
Biomolecules. 2021 Oct 8;11(10):1483. doi: 10.3390/biom11101483.
2
CCNP1411 from the Baltic Sea-A New Producer of Nostocyclopeptides.
Mar Drugs. 2020 Aug 26;18(9):442. doi: 10.3390/md18090442.
3
Anabaenopeptins from CCNP1411.
Int J Environ Res Public Health. 2022 Sep 28;19(19):12346. doi: 10.3390/ijerph191912346.
5
Bioactive Peptides Produced by Cyanobacteria of the Genus : A Review.
Mar Drugs. 2019 Sep 29;17(10):561. doi: 10.3390/md17100561.
7
Noncovalent inhibitors of human 20S and 26S proteasome based on trypsin inhibitor SFTI-1.
Biopolymers. 2016 Sep;106(5):685-96. doi: 10.1002/bip.22886.
8
Design, synthesis and biological evaluation of dipeptides as novel non-covalent 20S proteasome inhibitors.
J Asian Nat Prod Res. 2021 May;23(5):436-451. doi: 10.1080/10286020.2021.1910241. Epub 2021 Apr 12.
9
Insight into Inhibitor Binding in the Eukaryotic Proteasome: Computations of the 20S CP.
Int J Mol Sci. 2018 Dec 3;19(12):3858. doi: 10.3390/ijms19123858.
10
Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium tuberculosis Proteasome.
ACS Infect Dis. 2017 Feb 10;3(2):176-181. doi: 10.1021/acsinfecdis.6b00172. Epub 2016 Dec 5.

引用本文的文献

1
Chemical diversity of cyanobacterial natural products.
Nat Prod Rep. 2025 Jan 22;42(1):6-49. doi: 10.1039/d4np00040d.

本文引用的文献

1
Proteasomal adaptations to FDA-approved proteasome inhibitors: a potential mechanism for drug resistance?
Cancer Drug Resist. 2021;4(3):634-645. doi: 10.20517/cdr.2021.27. Epub 2021 May 30.
3
Identification of proteasome inhibitors using analysis of gene expression profiles.
Eur J Pharmacol. 2020 Dec 15;889:173709. doi: 10.1016/j.ejphar.2020.173709. Epub 2020 Nov 6.
4
Proteasome, a Promising Therapeutic Target for Multiple Diseases Beyond Cancer.
Drug Des Devel Ther. 2020 Oct 19;14:4327-4342. doi: 10.2147/DDDT.S265793. eCollection 2020.
5
Updates to the drug-resistant mechanism of proteasome inhibitors in multiple myeloma.
Asia Pac J Clin Oncol. 2021 Feb;17(1):29-35. doi: 10.1111/ajco.13459. Epub 2020 Sep 13.
7
CCNP1411 from the Baltic Sea-A New Producer of Nostocyclopeptides.
Mar Drugs. 2020 Aug 26;18(9):442. doi: 10.3390/md18090442.
8
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.
Pharmacol Ther. 2020 Sep;213:107579. doi: 10.1016/j.pharmthera.2020.107579. Epub 2020 May 19.
10
Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease.
Molecules. 2020 Feb 5;25(3):671. doi: 10.3390/molecules25030671.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验